EUVIMEDEUVIMED entdecken
Crossref

Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes

Dipanwita Sadhukhan iD, Raktim Chowdhury iD, Saranya Roy, Arunima Roy, Shreyosi Maitra, Kartik Chandra Ghosh iD, Joydeep Mukherjee iD, Tapas Kumar Banerjee iD, Subhra Prakash Hui iD, Saikat Chakrabarti iD, Arindam Biswas iD

European Journal of Neuroscience · 2026

DOI: 10.1111/ejn.70684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2026. Verfasst von Dipanwita Sadhukhan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology & Clinical Neuroscience Division, National Neurosciences Centre Calcutta, Kolkata, India. Hauptthemen laut MEDLINE: Stroke, Receptor, trkB, Membrane Glycoproteins, Memory. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Department of Science & Technology, Government of India, Department of Science & Technology and Biotechnology, Government of West Bengal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post‐stroke cognitive impairment (PSCI) affects nearly 30% of stroke survivors and substantially limits functional recovery. Brain‐derived neurotrophic factor (BDNF)–tropomyosin receptor kinase‐ β (Trk β ) signalling plays an important role in synaptic plasticity and cognitive function; however, the contribution of individual NTRK2/Trk β isoforms to PSCI remains poorly understood. This study investigated (a) isoform‐specific NTRK2 mRNA expression, (b) genetic association of the isoform‐specific variant rs6559833 with post‐stroke cognitive outcomes and (c) DNA methylation patterns potentially regulating NTRK2 expression using blood as primary biosource. Isoform‐specific expression was analysed in 50 subjects, rs6559833 was genotyped in 280 ischemic stroke patients, and DNA methylation was assessed in 10 samples using whole‐genome bisulfite sequencing. The TRK β ‐FL expression was significantly reduced in stroke patients compared with healthy controls, whereas TRK β ‐SHC expression was higher in PSCN individuals than in PSCI patients. The latter showed positive correlation with MEK2 expression and memory performance. The ‘TT’ genotype of the rs6559833 variant showed marginal associations with post‐stroke memory status and overall BMSE scores ( p = 0.0442 and 0.0488, respectively). Furthermore, hypermethylation was observed within the NTRK2 gene body and in genes encoding its splicing regulators, whereas no evident difference in promoter methylation was observed. Collectively, these findings suggest that Trk β ‐SHC expression may be associated with preserved cognitive function after stroke and indicate a potential relationship between isoform‐specific NTRK2 expression, genetic regulation and cognitive outcomes in PSCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StrokeReceptor, trkBMembrane GlycoproteinsMemoryCognitive DysfunctionSrc Homology 2 Domain-Containing, Transforming Protein 1HumansFemaleMaleDNA MethylationAgedProtein IsoformsMiddle Aged

Stichwörter der Autor:innen

DNA methylationMEK2PBMCTRKβ isoformgene expressiongenetic variantpost‐stroke outcome

Substanzen

Protein Isoformstropomyosin-related kinase-B, humanReceptor, trkBMembrane GlycoproteinsSrc Homology 2 Domain-Containing, Transforming Protein 1

Autor:innen und Institutionen

  • Molecular Biology & Clinical Neuroscience Division, National Neurosciences Centre Calcutta, Kolkata, India.
  • Institute of Engineering and Management-Newtown, University of Engineering & Management, Kolkata, India.
  • Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, IICB-TRUE Campus, Kolkata, India.
  • Department of Biomedical Science & Technology, School of Biological Sciences, Ramakrishna Mission Vivekananda Educational & Research Institute, Narendrapur, India.
  • Department of Neurology, Nil Ratan Sircar Medical College & Hospital, Kolkata, India.
  • S. N. Pradhan Centre for Neurosciences, University of Calcutta, Kolkata, India.

ORCID-Profile: Dipanwita Sadhukhan, Raktim Chowdhury, Kartik Chandra Ghosh, Joydeep Mukherjee, Tapas Kumar Banerjee, Subhra Prakash Hui, Saikat Chakrabarti, Arindam Biswas

Förderung

  • Department of Science & Technology, Government of India
  • Department of Science & Technology and Biotechnology, Government of West Bengal

Zitieren

APA

Sadhukhan, D., Chowdhury, R., Roy, S., Roy, A., Maitra, S., Ghosh, K. C., Mukherjee, J., Banerjee, T. K., Hui, S. P., Chakrabarti, S., & Biswas, A. (2026). Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes. European Journal of Neuroscience. https://doi.org/10.1111/ejn.70684

Vancouver

Sadhukhan D, Chowdhury R, Roy S, Roy A, Maitra S, Ghosh KC, et al. Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes. European Journal of Neuroscience. 2026. doi:10.1111/ejn.70684

BibTeX
@article{Sadhukhan2026,
  author = {Sadhukhan, Dipanwita and Chowdhury, Raktim and Roy, Saranya and Roy, Arunima and Maitra, Shreyosi and Ghosh, Kartik Chandra and Mukherjee, Joydeep and Banerjee, Tapas Kumar and Hui, Subhra Prakash and Chakrabarti, Saikat and Biswas, Arindam},
  title = {Transcriptional Alteration in TRK β ‐SHC Isoform as a Neuroprotective Factor for Post‐Stroke Memory Outcomes},
  journal = {European Journal of Neuroscience},
  year = {2026},
  doi = {10.1111/ejn.70684}
}
Kostenlos starten →